Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
617.832.1205Share profile
Band 3
Provided by Jeffrey L Quillen
Jeffrey Quillen’s varied business law practice focuses on companies involved with advanced technology applications. He serves as outside general counsel to a number of emerging biotechnology, software and information technology companies. For these and other clients he negotiates and drafts agreements regarding intellectual property rights, including patent license agreements with major research universities and collaboration agreements with pharmaceutical companies.
On the financing side, Jeffrey represents venture capital funds and emerging companies in venture capital financing transactions, including private placements of convertible preferred stock and subordinated debt.
He also represents buyers and sellers in mergers and acquisitions, involving public and private companies. His work in this area includes helping foreign companies to acquire U.S. companies and organize international operations.
Jeffrey plays an active role in the leadership at Foley Hoag, serving on the firm’s Executive Committee, which works to further its strategic goals for client service, diversity, culture and overall growth.
Education: Duke University School of Law, JD; Colgate University, BA
Provided by Chambers
Provided by Chambers
Jeffrey has a good reputation in this space.
Jeffrey has a good reputation in this space.
1 item provided by Foley Hoag LLP
Pitchbook Recognizes Foley Hoag Among Top 20 Firms Globally Across All Venture Deals
Foley Hoag has again been named among the most active law firms in venture capital financings in Pitchbook’s 2024 Annual Global League Tables.
Pitchbook Recognizes Foley Hoag Among Top 20 Firms Globally Across All Venture Deals
Foley Hoag has again been named among the most active law firms in venture capital financings in Pitchbook’s 2024 Annual Global League Tables.
Provided by Foley Hoag LLP
Health and Life Sciences
Technology, Media and Telecoms (TMT)
Financial Investors